As of 2025-09-18, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (30.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -219.2%.
The range of the Relative Valuation is (24.48) - (34.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (24.48) - (34.30) | (30.50) |
| Upside | -195.7% - -234.1% | -219.2% |
| Date | P/E |